Evaluation of the effect of vitamin B12, folic acid, and vitamin E on Multiple sclerosis amelioratio
Phase 3
Recruiting
- Conditions
- multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20230913059422N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Relapsing-remitting Multiple Sclerosis (RRMS) according to McDonald's diagnostic criteria
EDSS score equal to 6 or less (EDSS = 6)
Body mass index (BMI) above 17 and below 30
Age between 18 and 65 years
Informed consent
Exclusion Criteria
Atrophy of the optic nerve (Leber's disease)
Consumption of aminoglycosides, chloramphenicol, colchicine, continuous potassium release products, aminosalicylic acid and its solutions, anticonvulsant drugs and alcohol
Taking folate, vitamin B12 and vitamin E supplements up to one year before the start of the study
Thyroid disorders
IBD
IBS
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method